Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 1/20 | 0.86 |
| ▸ | HCAR2 | Q8TDS4 | 4/20 | 0.84 |
| ▸ | MAPT | P10636 | 1/20 | 0.61 |
| ▸ | RAB9A | P51151 | 1/20 | 0.61 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.61 |
| ▸ | TSHR | P16473 | 3/20 | 0.59 |
| ▸ | HPGD | P15428 | 1/20 | 0.59 |
| ▸ | NAAA | Q02083 | 1/20 | 0.56 |
| ▸ | APP | P05067 | 4/20 | 0.54 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | HTT | P42858 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL462473 | 1.00 | ATM (0.86) | ATMHCAR2MAPTRAB9ANPSR1 | |
| SCHEMBL1305254 | 1.00 | ATM (0.86) | ATMHCAR2MAPTRAB9ANPSR1 | |
| SCHEMBL18209632 | 0.98 | HCAR2 (0.85) | ATMHCAR2MAPTRAB9ANPSR1 | |
| SCHEMBL357423 | 0.98 | HCAR2 (0.85) | ATMHCAR2MAPTRAB9ANPSR1 | |
| SCHEMBL42963 | 0.98 | HCAR2 (0.85) | ATMHCAR2MAPTRAB9ANPSR1 | |
| SCHEMBL1305378 | 0.98 | HCAR2 (0.85) | ATMHCAR2MAPTRAB9ANPSR1 | |
| SCHEMBL9318682 | 0.98 | HCAR2 (0.85) | ATMHCAR2MAPTRAB9ANPSR1 | |
| SCHEMBL7780534 | 0.98 | HCAR2 (0.85) | ATMHCAR2MAPTRAB9ANPSR1 | |
| SCHEMBL440694 | 0.98 | HCAR2 (0.85) | ATMHCAR2MAPTRAB9ANPSR1 | |
| SCHEMBL356935 | 0.98 | HCAR2 (0.85) | ATMHCAR2MAPTRAB9ANPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 591 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12630661-B2 | Additives useful in 3D printing technologies | Evonik Operations GmbII (DE) | 2026-05-19 | — | — | US | claimed |
| CN-119656881-B | Reverse osmosis membrane with coralloid structure and preparation method and application thereof | 苏州实验室 | 2025-05-23 | — | — | CN | claimed |
| CN-119823825-A | Myrtle essential oil and application of compound essential oil based on myrtle essential oil in pest control | 广东海洋大学 | 2025-04-15 | — | — | CN | claimed |
| CN-119656881-A | Reverse osmosis membrane with coralloid structure and preparation method and application thereof | 苏州实验室 | 2025-03-21 | — | — | CN | claimed |
| CN-117659598-A | Bio-based conveyor belt covering adhesive and preparation method thereof | 北京化工大学 | 2024-03-08 | — | — | CN | claimed |
| CN-117164760-A | Functionalized fumarate/conjugated diene copolymer, preparation method thereof and bio-based elastomer | 北京化工大学 | 2023-12-05 | — | — | CN | claimed |
| CN-115073665-B | Fumarate/conjugated diene copolymer type bio-based rubber, preparation method thereof and vulcanized rubber product thereof | 北京化工大学 | 2023-08-29 | — | — | CN | claimed |
| US-20230120872-A1 | ADDITIVES USEFUL IN 3D PRINTING TECHNOLOGIES | EVONIK OPERATIONS GMBH (DE) | 2023-04-20 | — | — | US | claimed |
| EP-4166332-A1 | ADDITIVES USEFUL IN 3D PRINTING TECHNOLOGIES | Evonik Operations GmbH (DE) | 2023-04-19 | — | — | EP | claimed |
| CN-115960328-A | Additives for 3D printing techniques | 赢创运营有限公司 | 2023-04-14 | — | — | CN | claimed |
| US-20080299196-A1 | Controlled Release Pharmaceutical Compositions Comprising a Fumaric Acid Ester | ADITECH PHARMA AB (SE) | 2008-12-04 | — | — | US | claimed |
| EP-1951206-A1 | CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER | Aditech Pharma AB (SE) | 2008-08-06 | — | — | EP | claimed |
| EP-1799196-A2 | CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER | Aditech Pharma AB (SE) | 2007-06-27 | — | — | EP | claimed |
| WO-2007042034-A1 | CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER | ADITECH PHARMA AB (SE) | 2007-04-19 | — | — | WO | claimed |
| WO-2006037342-A2 | CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER | ADITECH PHARMA AB (SE) | 2006-04-13 | — | — | WO | claimed |
| EP-1608689-A1 | REMOVAL OF THIOCARBONYL END GROUPS OF POLYMERS | Symyx Technologies, Inc. (US) | 2005-12-28 | — | — | EP | claimed |
| US-6919409-B2 | Removal of the thiocarbonylthio or thiophosphorylthio end group of polymers and further functionalization thereof | SYMYX TECHNOLOGIES, INC. (US) | 2005-07-19 | — | — | US | claimed |
| US-20040266953-A1 | Removal of the thiocarbonylthio or thiophosphorylthio end group of polymers and further functionalization thereof | SYMYX TECHNOLOGIES, INC. | 2004-12-30 | — | — | US | claimed |
| WO-2004089994-A1 | REMOVAL OF THIOCARBONYL END GROUPS OF POLYMERS | SYMYX TECHNOLOGIES, INC. (US) | 2004-10-21 | — | — | WO | claimed |
| US-4895926-A | Hydroxyethylnorbornene compounds and a process for their preparation | EASTMAN KODAK COMPANY (US) | 1990-01-23 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12630661-B2 | Additives useful in 3D printing technologies | HTR3D, HTR3B, HTR3C | ATM 1359/4885HCAR2 1679/4885MAPT 783/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.